{"AllianceGenome": "37212", "HGNC": "37212", "MIM": "612105", "_id": "100144748", "_version": 1, "accession": {"genomic": ["AC022016.7", "AC063965.8", "CP068268.2", "NC_000010.11", "NC_060934.1", "NG_007466.2", "NG_033079.1", "NW_013171807.1"], "protein": ["ACB45456.1", "B2CW77.1", "NP_001119521.1"], "rna": ["EU552092.1", "NM_001126049.2"], "translation": [{"protein": "NP_001119521.1", "rna": "NM_001126049.2"}, {"protein": "ACB45456.1", "rna": "EU552092.1"}]}, "alias": ["CWS4", "KILLIN"], "ensembl": [{"gene": "ENSG00000227268", "protein": "ENSP00000392204", "transcript": "ENST00000445946", "translation": [{"protein": "ENSP00000392204", "rna": "ENST00000445946"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000283059", "protein": ["ENSP00000489239", "ENSP00000495113"], "transcript": ["ENST00000635224", "ENST00000644082"], "translation": [{"protein": "ENSP00000489239", "rna": "ENST00000635224"}, {"protein": "ENSP00000495113", "rna": "ENST00000644082"}], "type_of_gene": "protein_coding"}], "entrezgene": "100144748", "exons": [{"cdsend": 87862487, "cdsstart": 87861950, "chr": "10", "position": [[87859159, 87863533]], "strand": -1, "transcript": "NM_001126049", "txend": 87863533, "txstart": 87859159}, {"cdsend": 78311, "cdsstart": 77774, "chr": "10_KQ090021v1_fix", "position": [[74980, 79357]], "strand": -1, "transcript": "NM_001126049", "txend": 79357, "txstart": 74980}], "exons_hg19": [{"cdsend": 89622244, "cdsstart": 89621707, "chr": "10", "position": [[89618915, 89623290]], "strand": -1, "transcript": "NM_001126049", "txend": 89623290, "txstart": 89618915}], "generif": [{"pubmed": 18385383, "text": "Killin is a p53-regulated nuclear inhibitor of DNA synthesis with high affinity of DNA binding."}, {"pubmed": 18385383, "text": "results support Killin as a missing link between p53 activation and S phase checkpoint control designed to eliminate replicating precancerous cells, should they escape G(1) blockade mediated by p21."}, {"pubmed": 21177507, "text": "Germline KILLIN methylation is common among patients with Cowden syndrome or Cowden-like syndrome and is associated with increased risks of breast and renal cancer over PTEN mutation-positive individuals"}, {"pubmed": 21584899, "text": "19 of 20 advanced RCC showed somatic hypermethylation upstream of KILLIN"}, {"pubmed": 21956414, "text": "Cowden syndrome patients have elevated risks of papillary thyroid cancer from KLLN alterations."}, {"pubmed": 22580995, "text": "Pathogenic mutations in KLLN are rare in breast cancer families and the c.339_340delAG variant does not represent a high-penetrance breast cancer risk allele."}, {"pubmed": 23386643, "text": "KLLN is a transcription factor directly regulating AR, TP53, and TP73 expression, with a role in prostate carcinogenesis."}, {"pubmed": 23418309, "text": "We demonstrate, in vitro and in murine xenograph models, that both KLLN and PTEN are AR-target genes, mediating androgen-induced growth inhibition and apoptosis in breast cancer cells."}, {"pubmed": 23446638, "text": "Germline KLLN mutations dysregulate the cell cycle at G2."}, {"pubmed": 24356815, "text": "Data indicate that NVP-BEZ235-induced androgen receptor (AR) suppression resulted in decreased expression of both tumor suppressor proteins PTEN and KLLN in AR+/ER+ breast cancer cells."}, {"pubmed": 24972837, "text": "Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma"}, {"pubmed": 25669429, "text": "Germline promoter hypermethylation of KLLN is associated with particular malignant and benign Cowden syndrome features, which is dependent on the PTEN mutation status."}, {"pubmed": 25945611, "text": "Killin has a role in competitively inhibiting the formation of DNA replication forks during S-phase, as well as potentially negatively regulate RNA synthesis during other cell cycle phases"}, {"pubmed": 26673699, "text": "The results suggest a critical role for KLLN as a potential regulator of pericentric heterochromatin formation, genomic stability and gene expression."}, {"pubmed": 27663866, "text": "overexpression of microRNA-224 enhanced the proliferation abilities of HO8910 and knockdown of microRNA-224 suppressed the proliferation abilities of HO8910PM by KLLN-cyclin A pathway."}, {"pubmed": 28755140, "text": "Data suggest that low levels of PTEN and KLLN are associated with both sporadic papillary thyroid carcinoma and multi-nodular goiter (as compared to control subjects); however, PTEN and KLLN should not be considered as circulating biomarkers for differential diagnosis between malignancy and benignity in indeterminate thyroid nodules. (PTEN = phosphatase and tensin homolog; KLLN = DNA replication inhibitor killin)"}, {"pubmed": 30664260, "text": "MiR-744-3p regulates the proliferation and differentiation of keratinocytes through targeting KLLN in psoriasis"}, {"pubmed": 34425332, "text": "New evidence on tumor suppressor activity of PTEN and KLLN in papillary thyroid carcinoma."}, {"pubmed": 38015024, "text": "EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN."}], "genomic_pos": [{"chr": "10", "end": 87863533, "ensemblgene": "ENSG00000227268", "start": 87859158, "strand": -1}, {"chr": "HG2334_PATCH", "end": 78311, "ensemblgene": "ENSG00000283059", "start": 77778, "strand": -1}], "genomic_pos_hg19": {"chr": "10", "end": 89623194, "start": 89618918, "strand": -1}, "go": {"BP": {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006915", "qualifier": "involved_in", "term": "apoptotic process"}, "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}], "MF": {"category": "MF", "evidence": "IEA", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}}, "homologene": {"genes": [[9544, 100426503], [9598, 100610121], [9606, 100144748]], "id": 129876}, "ipi": "IPI00890812", "map_location": "10q23.31", "name": "killin, p53 regulated DNA replication inhibitor", "other_names": "killin", "pharmgkb": "PA166049027", "pharos": {"target_id": 10305, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": {"id": "GNF232300", "relationship": "is"}}, "refseq": {"genomic": ["NC_000010.11", "NC_060934.1", "NG_007466.2", "NG_033079.1", "NW_013171807.1"], "protein": "NP_001119521.1", "rna": "NM_001126049.2", "translation": {"protein": "NP_001119521.1", "rna": "NM_001126049.2"}}, "reporter": {"HG-U133_Plus_2": "244431_at", "HTA-2_0": "TC10001493.hg.1", "HuEx-1_0": ["3299305", "3299307"], "HuGene-2_1": "16716320"}, "summary": "The protein encoded by this intronless gene is found in the nucleus, where it can inhibit DNA synthesis and promote S phase arrest coupled to apoptosis. The expression of this DNA binding protein is upregulated by transcription factor p53. [provided by RefSeq, Dec 2012].", "symbol": "KLLN", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C2677502"}, "unigene": "Hs.559820", "uniprot": {"Swiss-Prot": "B2CW77"}}